Skip to main content
. 2026 Feb 27;11(2):aakag015. doi: 10.1093/esj/aakag015

Figure 4.

Figure 4

Kaplan–Meier cumulative estimates of (A) 90-day new ischaemic stroke or TIA and (B) 90-day moderate-to-severe bleeding in patients with active cancer, cancer in remission vs no cancer in the weighted cohort. Panels on the right indicate the HR (95% CIs) for 90-day new ischaemic stroke or TIA (A) and moderate-to-severe bleeding in respect to patients without cancer. Abbreviation: HR = hazard ratio.